Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

4-Hydroxytolbutamide

4-Hydroxytolbutamide is listed in the pharmaceutical impurity collection under CAS 5719-85-7. Its represented structure has formula C12H18N2O4S and a calculated molecular weight of 286.35 g/mol.

2D chemical structure

N H O N H S O O O H

Chemical identity

Catalog name
4-Hydroxytolbutamide
Common name
4-Hydroxytolbutamide
Chemical name
1-butyl-3-[4-(hydroxymethyl)phenyl]sulfonylurea
CAS
5719-85-7
SMILES
CCCCNC(=O)NS(=O)(=O)c1ccc(CO)cc1
InChI
InChI=1S/C12H18N2O4S/c1-2-3-8-13-12(16)14-19(17,18)11-6-4-10(9-15)5-7-11/h4-7,15H,2-3,8-9H2,1H3,(H2,13,14,16)
InChIKey
SJRHYONYKZIRPM-UHFFFAOYSA-N

Record ID: A17940c038279

Computed properties

C12H18N2O4S Molecular formula
286.353 g/molMolecular weight
286.0987 DaMonoisotopic exact mass
95.5 ŲTopological polar surface area
0.9669 Calculated LogP (Wildman–Crippen)
70.993 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O S 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight286.35340.00
Calculated LogP (Wildman–Crippen)0.966924.88
Topological polar surface area95.569.26
Hydrogen-bond acceptors450.68
Hydrogen-bond donors381.39
Rotatable bonds (strict)669.73

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC12H18N2O4Sdimensionless
Molecular weight286.353g/mol
Monoisotopic exact mass286.0987Da
Topological polar surface area95.5Ų
Calculated LogP (Wildman–Crippen)0.9669dimensionless
Molar refractivity (Wildman–Crippen)70.993cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors3count
Rotatable bonds (strict)6count
Heavy atoms19count
Heteroatoms7count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.4167fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area112.4373Ų
Valence electrons106count
Radical electrons0count
Bertz complexity511.0359index
Balaban J2.6634index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 4-Hydroxytolbutamide

Qualification and safety assessment of 4-Hydroxytolbutamide

Explore toxicological qualification of 4-Hydroxytolbutamide and ICH M7 mutagenic impurity assessment of 4-Hydroxytolbutamide for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 4-Hydroxytolbutamide and acceptable intake and limit justification for 4-Hydroxytolbutamide. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 4-Hydroxytolbutamide

Explore Altox services and software through the Altox Pharma-Hub.